Integrated, Infinitopes

Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers

Published on 08/07/2025 at 18:05 | prnewswire.co.uk

Infinitopes United Kingdom United States of America England Japan Singapore

en | CH0038389992 | INTEGRATED | boerse | 67972864 |